Consolidated Statements of Assets and Liabilities - USD ($) $ in Thousands	Sep. 30, 2023		Dec. 31, 2022
ASSETS
Investments at fair value:	$ 929,632	[1]	$ 71,758	[2]
Cash, cash equivalents and restricted cash	147,396		19,486
Interest receivable for non-controlled/non-affiliated investments	10,171		356
Deferred financing costs	6,355		335
Deferred offering costs	1,594		0
Unrealized appreciation on foreign currency forward contracts	141		0
Receivable for investments sold	935		65
Total assets	1,096,224		92,000
LIABILITIES
Debt	383,630		31,000
Payable for investments purchased	205,817		10,894
Interest payable	6,460		103
Distribution payable	2,290		0
Board of Trustees fee payable	0		92
Accrued expenses and other liabilities	3,816		216
Total liabilities	602,013		42,305
Commitments and contingencies
NET ASSETS
Common shares	180		20
Additional paid in capital	478,146		49,980
Distributable earnings (loss)	15,885		(305)
Total net assets	494,211		49,695
Total liabilities and net assets	$ 1,096,224		$ 92,000
NET ASSET VALUE PER SHARE (in dollars per share)	$ 27.49		$ 24.85

[1] Unless otherwise indicated, issuers of debt investments held by the Company (which such term “Company” shall include the Company’s subsidiaries for purposes of this Schedule of Investments) are denominated in dollars. All debt investments are income producing unless otherwise indicated.

[2] Unless otherwise indicated, issuers of debt investments held by the Company (which such term “Company” shall include the Company’s subsidiaries for purposes of this Schedule of Investments) are denominated in dollars. All debt investments are income producing unless otherwise indicated.